Home › Trial NCT01703572
A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies
- Trial IDNCT01703572
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorOncoMed Pharmaceuticals, Inc.
- Enrollment24
- Start date2012-10
- ConditionsRelapsed or Refractory Lymphoid Malignancies
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.